Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2011-04-18
Original SEC Filing: Click here

---

Webplus: SVA/20110418/6-K/2_EX-99.1/000.htm SEC Original: v218787_ex99-1.htm
Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group Unblinded Results Show Good Safety Profile and Preliminary Immunogenicity Source: Sinovac Biotech Ltd. On Thursday March 10, 2011, 8:00 am EST BEIJING, March 10, 2011 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq:SVA – News), a leading provider of biopharmaceutical products in China, announced today the unblinding

---

---

Webplus: SVA/20110418/6-K/1/000.htm SEC Original: v218787_6k.htm
SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2011-04-18CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085